Feasibility analysis of opioid-free anesthesia in short urological surgery

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200055979

Enrollment

Unknown

Registered

2022-01-30

Start date

2022-03-01

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

short urological surgery

Interventions

opioid-free anesthesia group:Combined esticketamine, dexmedetomidine and lidocaine anesthesia

remifentanil anesthesia group:Remifentanil anesthesia

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years, BMI 18-28 kg/m2, ASA I/II; 2. Operation time < 2 h; 3. The surgical types were short urological operations, such as ureteral lithotripsy, cystoscopy, and/or ureteroscopy combined cystostomy, etc.

Exclusion criteria

Exclusion criteria: 1. Serious diseases of heart, liver, kidney, lung and other important organs; 2. Long-term use of analgesics, anticoagulants or alcohol abuse; 3. History of anaesthesia related drug allergy; 4. Participants in other drug trials within three months.

Design outcomes

Primary

Measure	Time frame
blood pressure;heart rate;BIS;SpO2;	—

Secondary

Measure	Time frame
Perioperative adverse events;	—

Countries

China

Contacts

Public ContactJi Muhuo

the Second Affiliated Hospital of Nanjing Medical University

jimuhuo2009@sina.com+86 15996235006

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026